Marsh & McLennan Companies (MRSH) Financials

Marsh & McLennan’s financial profile has strengthened over the period provided, although rising interest costs and uneven working-capital cash flow remain important risks. Quarterly revenue increased from $4.655 billion in Q3 2022 to $7.157 billion in Q2 2026. Over the same comparison, consolidated net income rose from $552 million to $1.291 billion, while diluted EPS increased from $1.08 to $2.63. The company’s latest quarter also showed year-over-year growth, with revenue up approximately 6.1%, net income up 4.9% and diluted EPS up 7.3% from Q2 2025.

Profitability has benefited from the company’s largely fee-based, non-interest income model. Non-interest income reached $7.399 billion in Q2 2026 and accounted for essentially all reported revenue, offsetting a $242 million net interest expense. However, expense growth has been substantial: salaries and employee benefits increased to $4.141 billion in Q2 2026 from $3.895 billion a year earlier, while total non-interest expense rose 7.0% year over year.

Cash generation improved sequentially but remains volatile. Operating cash flow was negative $688 million in Q1 2026 before rebounding to $1.523 billion in Q2. The latest quarter produced a $548 million increase in cash and equivalents despite $800 million of financing outflows, including $757 million of share repurchases and $451 million of dividends. Investors should also distinguish between cash and restricted cash: the balance sheet reported $1.7 billion of cash and due from banks, alongside $12.2 billion of restricted cash.

• Strong earnings growth: Diluted EPS increased from $1.08 in Q3 2022 to $2.63 in Q2 2026, reflecting both higher earnings and a gradual reduction in diluted shares outstanding from roughly 503 million to 482 million.
• Consistent revenue expansion: Quarterly revenue advanced from $4.655 billion in Q3 2022 to $6.381 billion in Q4 2025 and $7.157 billion in Q2 2026, indicating sustained business growth despite quarterly seasonality.
• Large non-interest income base: Non-interest income of $7.399 billion in Q2 2026 substantially exceeded the company’s interest expense, reducing the importance of interest-rate-sensitive revenue to overall results.
• Shareholder returns remain substantial: Marsh & McLennan repurchased $757 million of common stock and paid $451 million in dividends in Q2 2026. The reduction in weighted-average shares suggests buybacks have supported per-share earnings.
• Improved balance-sheet equity: Total equity and noncontrolling interests increased from $10.749 billion at year-end 2022 to $15.433 billion at June 30, 2026, while total assets rose to $59.682 billion.
• Q2 operating cash flow recovered: Operating cash flow improved from negative $688 million in Q1 2026 to positive $1.523 billion in Q2, and Q2 net cash generation of $548 million exceeded the $365 million reported in Q2 2025.
• Working-capital swings drive cash-flow volatility: Changes in operating assets and liabilities reduced operating cash flow by $2.252 billion in Q1 2026 but had only a $66 million negative effect in Q2. This appears to be a timing-related pattern, but it makes quarterly cash flow less predictable.
• Acquisition and intangible-asset exposure: Goodwill and intangible assets totaled approximately $28.9 billion at June 30, 2026, or about 48% of total assets. This supports the company’s acquisition-driven growth strategy but increases potential impairment risk.
• Interest expense is rising: Long-term debt interest expense increased from $127 million in Q4 2022 to $250 million in Q2 2026. Net interest expense reached $242 million in the latest quarter, creating a growing drag on pretax income.
• Debt and operating-cost pressures could limit margin expansion: Total debt was approximately $20.6 billion at June 30, 2026, while total liabilities reached $44.2 billion. At the same time, Q2 2026 non-interest expenses grew faster than revenue, causing the pretax margin to edge lower from roughly 24.4% in Q2 2025 to 23.8%.